The State of Drug Pricing Reform in 2023

Drug pricing reform in the U.S. is both further along than it’s been in years and stuck facing the same long odds that have frustrated past attempts at a major federal overhaul. If recent actions from Congress and the White House are any indicati…

Unlocking AI: Shaping the Firm of the Future

As the Advisory Services landscape continues to evolve, AI technologies will increasingly be indispensable for enhancing practitioner work and delivering modern services experiences. However, success with AI isnʼt simply about whether firms adopt the t…